L-Ornithine L-Aspartate
Mechanism :
These are amino acid preparations used as hepatobiliary preparations in the treatment of acute and chronic liver disease.
Indication :
- Hepatic encephalopathy
- Hepatitis
Contraindications :
Hypersensitivity to drug/class/component.
Dosing :
Pediatric dose not established.
Adult dose:
300 mg IV 12 hourly or 600 mg PO 12 hourly for 3-4 weeks.
Adverse Effect :
Nausea and vomiting. It is contraindicated in patients with renal insufficiency.
Interaction :
No known interactions.
Hepatic Dose :
No dosage adjustments are recommended.